Table 1 Clinical characteristics of the control and isosorbide mononitrate groups
Variables | 0 Week | 4 Weeks | 12 Weeks |
|---|---|---|---|
Control group (n=15) | |||
Body mass index (kg m−2) | 24.1±2.5 | 24.0±2.2 | 24.1±2.6 |
Systolic blood pressure (mm Hg) | 136.8±12.5 | 135.9±13.1 | 135.2±12.8 |
Diastolic blood pressure (mm Hg) | 84.1±9.6 | 83.2±8.9 | 83.6±9.1 |
Heart rate (b.p.m.) | 68.9±8.6 | 67.9±7.9 | 70.1±8.8 |
Total cholesterol (mmol l−1) | 4.97±0.81 | 4.96±0.88 | 4.92±0.76 |
Triglycerides (mmol l−1) | 1.21±0.42 | 1.19±0.41 | 1.17±0.39 |
HDL cholesterol (mmol l−1) | 1.38±0.31 | 1.39±0.34 | 1.40±0.35 |
LDL cholesterol (mmol l−1) | 3.54±0.83 | 3.50±0.78 | 3.49±0.75 |
Serum glucose (mmol l−1) | 4.9±0.4 | 4.9±0.4 | 4.9±0.3 |
Smoker (n) | 4 | ||
Isosorbide mononitrate group (n=15) | |||
Body mass index (kg m−2) | 24.2±2.3 | 24.1±2.4 | 24.3±2.5 |
Systolic blood pressure (mm Hg) | 137.9±13.4 | 134.7±12.9 | 134.2±12.7 |
Diastolic blood pressure (mm Hg) | 83.7±9.7 | 80.4±9.0 | 80.1±8.8 |
Heart rate (b.p.m.) | 71.2±9.3 | 71.8±9.5 | 70.8±9.1 |
Total cholesterol (mmol l−1) | 4.93±0.85 | 4.88±0.93 | 4.95±0.91 |
Triglycerides (mmol l−1) | 1.23±0.45 | 1.21±0.43 | 1.18±0.39 |
HDL cholesterol (mmol l−1) | 1.40±0.25 | 1.42±0.33 | 1.39±0.31 |
LDL cholesterol (mmol l−1) | 3.47±0.75 | 3.46±0.71 | 3.44±0.74 |
Serum glucose (mmol l−1) | 4.8±0.3 | 4.9±0.4 | 4.8±0.3 |
Smoker (n) | 5 | ||
